Septolete 30s menthol lozenges

The instruction for medical use of Septolete medicine menthol the Trade name of Septolete menthol the International unlicensed name Benzalkoniya chloride the Dosage form of the Tablet for resorption with taste of menthol Structure One tablet contains active agent - a benzalkoniya chloride of 1.00 mg, excipients: lactoses monohydrate, peppermint oil, oil eucalyptus, left menthol, methyl-isopropyl phenol, liquid paraffin, glycerin, castor oil of a cold extraction, defoamer 1510 (sorbitol, glucose liquid, magnesium stearate, sucrose, a cover consists of dimethyl silicone (Dow Corning): quinolinic yellow (E104), indigotin blue (E132), the titan dioxide (E171), povidone, dripped 600 Pharm (consists of wax white bee, wax karnaubsky and shellac), sucrose. The description of the Tablet of round shape, biconvex, with a smooth surface, coated light green color. Pharmacotherapeutic group Drugs for treatment of diseases of a throat. ATX R02AA16 code the Pharmacological Pharmacokinetics Data properties about Septolete menthol are absent. Data on pharmacokinetics a benzalkoniya there is no chloride, but is well-known that quarternary compounds of ammonium are badly absorbed, i.e. from 10% - 20%, but not absorbed substance is removed in not changed view with a stake. Benzalkoniya's pharmacodynamics chloride is an antiseptic agent from group of quarternary compounds of ammonium. He acts as cationic surface substance. Thanks to the emulsifying properties, the benzalkoniya chloride depolarizes cytoplasmic membranes of microorganisms, that increasing their permeability. Thus, it makes bactericidal impact on gram-positive and gram-negative bacteria and Candida Albicans. Indications In complex therapy in slight infections of an oral cavity and throat (tonsillitis, pharyngitis, laryngitis) inflammation of gums and a mucous membrane of an oral cavity (ulitis, stomatitis) hoarseness, irritation and dryness in a throat elimination of an unpleasant smell the Route of administration and doses the Recommended dose for adults makes 8 tablets for resorption in day of a mouth. It is necessary to rassasyvat on the 1st tablet each 2 - 3 hours. A pill should not be taken just before or at meal time. The course of treatment should not exceed 7 days. Side effects Seldom (≥1/10.000 to & lt, 1/1.000): - gastrointestinal disorders, such as nausea, vomiting and diarrhea, stomach ache Very seldom (& lt, 1/10.000): allergic reactions which can be shown in the form of rash and an itching of hypersensitivity reaction If arise serious side effects, treatment has to be stopped. Contraindications hypersensitivity to active agent or to any excipients children's age up to 18 years Medicinal interactions Interaction of Septolete menthol with other medicines is not known. A pill for resorption should not be taken together with milk as milk the chloride benzalkoniya reduces antimicrobic efficiency. Special indications of the Dose of drug are higher than is appointed are not recommended. Patients with chronic cough or hoarseness should consult with the doctor. In heavier infections which are followed by fever, a headache and vomiting it is necessary to consult with the doctor, especially if the state does not improve within three days. Patients with diabetes should mean that each tablet for resorption contains lactose, sucrose, glucose and sorbitol. Special warnings of Septolete excipients tablet menthol for resorption with taste of menthol contain lactose, glucose, sucrose and sorbitol. Drug should not be used to patients with rare hereditary intolerance of a galactose or fructose, deficiency of enzyme of lactase, a syndrome of a malyabsorbation of glucose and a galactose or deficiency of sucrose-isomaltose. Pregnancy and the period of a lactation In connection with limited data on safety of use at pregnancy and a lactation, it is not recommended to take the drug at pregnancy and feeding by a breast. The feature of influence of medicine on ability to run the vehicle or potentially dangerous mechanisms was not reported about influence of Septolete menthol of tablets for resorption with taste of menthol on ability to drive the car and other mechanisms. Overdose cases of overdose of Septolete menthol were Not registered. Considering amount of active ingredients in each tablet for resorption, the overdose is almost impossible. When using doses above recommended there can be disturbances from digestive tract, such as nausea, vomiting and diarrhea. Treatment: patients have to be under intensive medical observation, therapy symptomatic and supporting. Presumably treatment has to include the induced vomiting and/or gastric lavage, maintenance therapy has to include keeping of the patient in heat. The form of release and packing On 15 tablets for resorption place in blister strip packaging from a film of polyvinylchloride/polyvinyldichloride and aluminum foil. On the 2nd blister strip packagings together with the instruction for medical use in the state and Russian languages place in a pack from cardboard Storage conditions to Store in original packing, at a temperature not over 25 ºС, in the place protected from moisture and light. To store out of children's reach! A period of storage 2 years not to use after an expiration date Prescription status Without prescription the Producer of KRK, of. The place, Slovenia is new, Shmaryeshka 6, 8501 the place, Slovenia the Owner of the registration certificate of KRK, of Is new, the place, Slovenia the Address of the organization accepting in the territory of the Republic of Kazakhstan claims from consumers on quality of products (goods) of KRKA Kazakhstan LLP, RK, 050059, Almaty, Al-Farabi Ave. 19, body 1, the 2nd floor, the 207th office Is new